Buscar

Mostrando ítems 1-10 de 24

Docking simulation between HIV peptidase inhibitors and Trypanosoma cruzi aspartyl peptidase

Castilho, Vanessa V. S.; Gonçalves, Keyla C. S.; Rebello, Karina M.; Baptista, Luiz P. R.; Sangenito, Leandro S.; Santos, Helena L. C.; Branquinha, Marta H.; Santos, André L. S.; Menna-Barreto, Rubem F. S.; Guimarães, Ana C.; d'Avila-Levy, C. M. (BMC, 2019)

Primary evidence of the mechanisms of action of HIV aspartyl peptidase inhibitors on Trypanosoma cruzi trypomastigote forms

Sangenito, Leandro S.; Menna-Barreto, Rubem F. S.; Oliveira, Ana Carolina; d`Avila-Levy, Claudia M.; Branquinha, Marta H.; Santos, André L. S. (Elsevier, 2018)

Nelfinavir is effective in inhibiting the multiplication and aspartic peptidase activity of Leishmania species, including strains obtained from HIV-positive patients

Santos, Lívia O.; Vitório, Bianca S.; Branquinha, Marta H.; Silva, Conceição M. Pedroso e; Santos, André L. S.; Levy, Cláudia M. d`Avila (Oxford University Press, 2015)

HIV aspartyl peptidase inhibitors interfere with cellular proliferation, ultrastructure and macrophage infection of Leishmania amazonensis

Santos, Lívia O.; Marinho, Fernanda A.; Altoé, Ellen F.; Vitório, Bianca S.; Alves, Carlos R.; Britto, Constança; Motta, Maria Cristina M.; Branquinha, Marta H.; Santos, André L. S.; d`Avila-Levy, Claudia M. (BioMed Central, 2019)

Repositioning drug strategy against Trypanosoma cruzi: lessons learned from HIV aspartyl peptidase inhibitors

Sangenito, Leandro Stefano; d’Avila-Levy, Claudia Masini; Branquinha, Marta Helena; Santos, André Luis Souza dos (Fiocruz/IOC, 2022)

Estudo comparativo das características bioquímicas funcionais e especificidade catalítica de aspartil, cisteíno e serino peptidases fúngicasComparative study of functional biochemical characteristics and catalytic specificity of aspartyl, cysteine and serine fungal peptidases

Silva, Ronivaldo Rodrigues da [UNESP] (Universidade Estadual Paulista (Unesp), 2016)

Docking simulation between HIV peptidase inhibitors and Trypanosoma cruzi aspartyl peptidase

Repositioning drug strategy against Trypanosoma cruzi: lessons learned from HIV aspartyl peptidase inhibitors

Sangenito, Leandro Stefano; d’Avila-Levy, Claudia Masini; Branquinha, Marta Helena; Santos, André Luis Souza dos (Fiocruz/IOC, 2022)

HIV aspartyl peptidase inhibitors interfere with cellular proliferation, ultrastructure and macrophage infection of Leishmania amazonensis

Primary evidence of the mechanisms of action of HIV aspartyl peptidase inhibitors on Trypanosoma cruzi trypomastigote forms

Sangenito, Leandro S.; Menna-Barreto, Rubem F. S.; Oliveira, Ana Carolina; d`Avila-Levy, Claudia M.; Branquinha, Marta H.; Santos, André L. S. (Elsevier, 2018)

Buscar

Filtros

Docking simulation between HIV peptidase inhibitors and Trypanosoma cruzi aspartyl peptidase

Primary evidence of the mechanisms of action of HIV aspartyl peptidase inhibitors on Trypanosoma cruzi trypomastigote forms

Nelfinavir is effective in inhibiting the multiplication and aspartic peptidase activity of Leishmania species, including strains obtained from HIV-positive patients

HIV aspartyl peptidase inhibitors interfere with cellular proliferation, ultrastructure and macrophage infection of Leishmania amazonensis

Repositioning drug strategy against Trypanosoma cruzi: lessons learned from HIV aspartyl peptidase inhibitors

Estudo comparativo das características bioquímicas funcionais e especificidade catalítica de aspartil, cisteíno e serino peptidases fúngicasComparative study of functional biochemical characteristics and catalytic specificity of aspartyl, cysteine and serine fungal peptidases

Docking simulation between HIV peptidase inhibitors and Trypanosoma cruzi aspartyl peptidase

Repositioning drug strategy against Trypanosoma cruzi: lessons learned from HIV aspartyl peptidase inhibitors

HIV aspartyl peptidase inhibitors interfere with cellular proliferation, ultrastructure and macrophage infection of Leishmania amazonensis

Primary evidence of the mechanisms of action of HIV aspartyl peptidase inhibitors on Trypanosoma cruzi trypomastigote forms